Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Tricia Elliott MD, FAAFP
Tricia C. Elliott MD, FAAFP Associate Editor
Peter Lin MD, CCFP
Peter Lin MD, CCFP Associate Editor
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
See All Experts
featured
Published in Primary Care and
1 other channel

Journal Scan / Research · April 13, 2016

Evolocumab Superior to Ezetimibe in Patients With Muscle-Related Statin Intolerance

JAMA: The Journal of the American Medical Association

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Paul Thompson MD

JAMA: The Journal of the American Medical Association
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial
JAMA 2016 Apr 03;[EPub Ahead of Print], SE Nissen, E Stroes, RE Dent-Acosta, RS Rosenson, SJ Lehman, N Sattar, D Preiss, E Bruckert, R Ceška, N Lepor, CM Ballantyne, I Gouni-Berthold, M Elliott, DM Brennan, SM Wasserman, R Somaratne, R Scott, EA Stein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated